African Americans and Medicaid patients are Less Likely to Access Robotic Prostate Surgery
Men who are of minor origin and those on the Medicaid are less likely to have their prostate cancer removed through robotic assisted prostate cancer surgery.
This fact was made known in a new study conducted by researchers from Mayo Clinic and published in the online edition of The Journal of Urology.
Dr. Otils Brawley, who is the chief medical and scientific officer of the American Cancer Society revealed, confirmed the fact of the study by stating: “People who are poor – frequently Hispanic, African American or black, and Medicaid patients – tend to get what is considered to be less high-quality care than those who are middle class and wealthy.”
However, even though the use of robotic assisted prostate cancer surgery has being impressive, the study researchers still reiterated the fact that there is no real evidence that have suggested the robotic surgery is better treatment than radical prostatectomy.
Details of the new study has been pointed out in a recent article posted January 4, 2013 by Andrew M. Seaman in Reuters as presented below: Despite a lack of evidence showing its superiority, robot-assisted prostate removal has become the predominant method since being approved by the U.S. Food and Drug Administration in 2000, according to the researchers, led by Dr. Simon Kim at the Mayo Clinic in Rochester, Minnesota.
Robotic surgical tools allow doctors to operate through small incisions with the aid of a tiny video camera, an approach that is considered less invasive but also tends to be more expensive.
Kim and his colleagues write in The Journal of Urology that evidence does exist to show that black patients are already less likely to get radiation or to have their prostates removed, but there is less data on whether they and other minorities have equal access to robot-assisted prostate removal.
For the study, Kim’s group used two national databases to compare the differences between the approximately 20,500 cancer patients who had their prostates removed at hospitals offering robotic surgery, and the 9,500 who had their surgery at hospitals without robots between 2006 and 2008.
Overall, the researchers found, the proportion of all prostate removals shifted from about 56 percent taking place at hospitals with robots in 2006 to 76 percent in 2008.
They also found that hospitals offering robotic surgery removed more than four times the number of prostates as other hospitals during that time.
That’s important because hospitals that remove more prostates tend to report better patient outcomes after surgery.
In addition, black patients were 19 percent less likely to have their surgery at a hospital using robots compared to white patients, and Hispanic patients were 23 percent less likely.
Medicaid patients were also 30 percent less likely to go to a hospital offering robotic surgery, compared to patients with private insurance.
Dr. Michael Barry, who was not involved in the new research but has studied prostate cancer treatment and outcomes, pointed out that the new work shows a gap in who is able to access the hospitals that perform the greatest number of prostate removals.
“The issue here is not access to robot (surgery) but high-volume hospitals,” said Barry, a clinical professor of medicine at Boston’s Harvard Medical School.
The study authors, who were not available for comment by press time, similarly conclude that gaps in access to robotic surgery hospitals may also indicate limited access to high-volume hospitals.
“More effective health care policies focusing on incentives to provide better access for minorities or for patients primarily insured by Medicaid may reduce disparities in access to high volume hospitals with robotic surgery,” they write.
Conclusively, the above study is useful in the sense that it can really help to bridge the gap on how the minority or those who are poor access better treatments for their prostate cancer conditions.
In other words, disparity in the provision of prostate healthcare can be minimized as those concerned should now be able to take concrete steps. You can access The Journal of Urology for facts on the new study.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- Robotic Prostate Cancer Surgery Too Costly than Open Surgery – Offers No Extraordinary Benefits
- Follow – Up Bladder Surgery Not Likely with Robotic Prostate Cancer Surgery – Dr. David Samadi
- The Value of Robotic Prostate Cancer Surgery in the Long Term Questioned
- Robotic Prostate Cancer Surgery
- Chief of Urologic Oncology at CINJ reaches a Milestone in Robotic Prostate Cancer Surgery
- Black Males (African Americans and others) and Prostate Cancer
- US Senate Declares Prostate Cancer among African Americans an Epidemic
- Robotic Prostate Surgery Yields Better Survival Rates Than Radiation Treatment – A World-Renowned Prostate Cancer Expert Reports
- Prostate Cancer Robotic Surgery and Success Rate – The Da Vinci Procedure
- The Benefits of Undergoing Laparoscopic Robotic Prostatectomy
- Prostate Cancer Treatment Guide – Helping You Access Relevant Prostate Cancer Information
- Robotic-Assisted Laparoscopic Radical Prostatectomy (RARP) Costlier than Radical Retropubic Prostatectomy (RRP)
- 4000th Robotic-Assisted Radical Prostatectomy to Be Performed By The Inventor Of SMART
- New Report Indicates Most Prostate Cancer Patients are satisfied after RALP Treatment
- SMART – A Robotic Approach to Get Rid of Prostate Cancer